1. Effect of RAGE gene polymorphisms and circulating sRAGE levels on susceptibility to gastric cancer: a case–control study
   Taijie Li et al, 2017, Cancer Cell Int CrossRef
2. Diabetes und restriktive Lungenerkrankungen/Fibrose
   S. Kopf, 2018, Diabetologe CrossRef
3. Long non-coding RNA AGER-1 functionally upregulates the innate immunity gene AGER and approximates its anti-tumor effect in lung cancer
   Zihua Pan et al, 2018, Mol Carcinog CrossRef
4. RAGE may act as a tumour suppressor to regulate lung cancer development
   Shuangshuang Wu et al, 2018, Gene CrossRef
5. Oxidation, glycation and glycoxidation—The vicious cycle and lung cancer
   Saheem Ahmad et al, 2017, Seminars in Cancer Biology CrossRef
6. The role of high-mobility group protein box 1 in lung cancer.
   Xiao-Jin Wu et al, 2018, J Cell Biochem CrossRef
7. Identification of genes associated with cancer progression and prognosis in lung adenocarcinoma: Analyses based on microarray from Oncomine and The Cancer Genome Atlas databases
   Wei Liu et al, 2018, Mol Genet Genomic Med CrossRef
8. Protein transduction therapy into cochleae via the round window niche in guinea pigs
   Hiroki Takeda et al, 2016, Molecular Therapy - Methods & Clinical Development CrossRef
9. Evaluation of functional RAGE gene polymorphisms in childhood acute lymphoblastic leukemia—A case-control study from Iran
   Ebrahim Eskandari-Nasab et al, 2017, Nucleosides, Nucleotides and Nucleic Acids CrossRef
10. Lung adenocarcinoma expressing receptor for advanced glycation end-products with primary systemic AL amyloidosis: a case report and literature review
    Shouichi Okamoto et al, 2017, BMC Cancer CrossRef
11. All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses.
    Elizabeth A Oczypok et al, 0 CrossRef
12. Determination of SIRT1 rs12778366, FGFR2 rs2981582, STAT3 rs744166, and RAGE rs1800625 Single Gene Polymorphisms in Patients with Laryngeal Squamous Cell Carcinoma
    Virgilijus Uloza et al, 2019, Disease Markers CrossRef
13. High glucose promotes tumor cell proliferation and migration in lung adenocarcinoma via the RAGE‑NOXs pathway
    Yuan‑Fan Liao et al, 2018, Mol Med Report CrossRef
14. The Gly82Ser mutation in AGER contributes to pathogenesis of pulmonary fibrosis in combined pulmonary fibrosis and emphysema (CPFE) in Japanese patients
    Takumi Kinjo et al, 2020, Sci Rep CrossRef
15. The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers
    Narasimha M. Beeraka et al, 2021, Cancers CrossRef
16. Elevated Expression of the RAGE Variant-V in SCLC Mitigates the Effect of Chemotherapeutic Drugs
    Bindhu K. Madhavan et al, 2021, Cancers CrossRef
17. The impact of receptor of advanced glycation end‐products polymorphisms on prostate cancer progression and clinicopathological characteristics
    Ying‐Erh Chou et al, 2021, J Cell Mol Med CrossRef
18. Role of Atypical Chemokines and Chemokine Receptors Pathways in the Pathogenesis of COPD
    Francesco Nucera et al, 2021, CMC CrossRef
19. null
    Charlotte Delrue et al, 2024 CrossRef
20. Identification of immunogenic cell death-related damage-related molecular patterns (DAMPs) to predict outcomes in patients with head and neck squamous cell carcinoma
    Jiayi Zhang et al, 2024, J Cancer Res Clin Oncol CrossRef